- Stocks
- Pharma & Healthcare
- Medi Assist Healthcare Services
Medi Assist Healthcare Services share price
NSE: MEDIASSISTPharma & HealthcareHealthcare Plans
Medi Assist Healthcare Services at a glance
Medi Assist Healthcare Services (NSE: MEDIASSIST) closed at ₹291.75 on 22 Oct 2026, down 0.61% on the day. With a market capitalisation of ₹2,179 Cr, it ranks 1104th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Healthcare Plans.
At its last close the stock traded at 24.1× trailing earnings, against a return on equity of 10.5% in FY26. Over the past year the share price has fallen 46.7%. Its 52-week range is ₹286.05 (21 Oct 2026) to ₹575.55 (3 Nov 2025); the last close is 49.3% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹242 Cr (+28.1% year on year) and net profit ₹54 Cr (+152.3%), on a consolidated basis. Promoters held 4.61% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹2,179 CrRank 1104 on NSE
- P/E (trailing)
- 24.1×
- Price to book
- 2.64×FY26
- EPS (TTM)
- ₹12.15to Q4 FY26
- ROE
- 10.5%FY26
- ROCE
- 12.4%FY26
- Debt to equity
- 0FY26
- Net profit margin
- 9.9%FY26
- Book value / share
- ₹112.44FY26
- 52-week high
- ₹575.553 Nov 2025
- 52-week low
- ₹286.0521 Oct 2026
- 1-year return
- −46.7%
- RSI (14-day)
- 35
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −0.61% | −4.7% | −13.9% | −16.4% | −46.7% |
Medi Assist Healthcare Services quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹168 Cr | ₹181 Cr | ₹186 Cr | ₹189 Cr | ₹191 Cr | ₹233 Cr | ₹240 Cr | ₹242 Cr |
| Revenue YoY | +19.1% | +12.2% | +12.0% | +13.2% | +13.6% | +28.6% | +28.9% | +28.1% |
| Net profit | ₹19 Cr | ₹21 Cr | ₹30 Cr | ₹22 Cr | ₹23 Cr | ₹8 Cr | ₹4 Cr | ₹54 Cr |
| Net profit YoY | +6.1% | +353.8% | +41.5% | −15.4% | +19.4% | −61.6% | −86.2% | +152.3% |
| Net margin | 11.3% | 11.6% | 16.1% | 11.4% | 11.9% | 3.5% | 1.7% | 22.5% |
| EPS | ₹2.68 | ₹2.99 | ₹4.20 | ₹3.05 | ₹3.18 | ₹1.13 | ₹0.51 | ₹7.33 |
Medi Assist Healthcare Services financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹323 Cr | ₹394 Cr | ₹505 Cr | ₹635 Cr | ₹723 Cr | — |
| Operating profit | ₹61 Cr | ₹78 Cr | ₹104 Cr | ₹105 Cr | ₹112 Cr | — |
| Net profit | ₹26 Cr | ₹64 Cr | ₹74 Cr | ₹69 Cr | ₹92 Cr | — |
| EPS (₹) | ₹4.00 | ₹9.00 | ₹11.00 | ₹10.00 | ₹13.00 | — |
| Cash from operations | ₹135 Cr | ₹64 Cr | ₹79 Cr | ₹66 Cr | ₹138 Cr | — |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹13 Cr | ₹0 Cr |
| Shareholders' equity | ₹290 Cr | ₹337 Cr | ₹377 Cr | ₹472 Cr | ₹541 Cr | ₹839 Cr |
Medi Assist Healthcare Services shareholding pattern
| Holder | 30 Jun 2025 | 30 Sep 2025 | 10 Oct 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 20.55% | 4.87% | 4.63% | 4.62% | 4.61% | 4.61% |
| Foreign institutions | 13.89% | 23.00% | 25.83% | 25.28% | 24.32% | 25.42% |
| Domestic institutions | 42.29% | 48.90% | 46.45% | 49.90% | 49.19% | 47.24% |
| Non-institutions | 23.27% | 23.24% | 23.09% | 20.20% | 21.89% | 22.74% |
Medi Assist Healthcare Services vs peers
The listed Pharma & Healthcare companies nearest to Medi Assist Healthcare Services by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| FREDUNFredun Pharmace | ₹1,376.10 | −0.35% | — | ₹2,276 Cr | 22.5 | — |
| DCALDishman Carbogen Amcis | ₹141.95 | +0.07% | −49.1% | ₹2,226 Cr | 22.8 | — |
| VIMTALABSVimta Labs | ₹495.55 | +2.15% | −28.3% | ₹2,214 Cr | 28.5 | — |
| MEDIASSISTMedi Assist Healthcare Services | ₹291.75 | −0.61% | −46.7% | ₹2,179 Cr | 24.1 | — |
| SYNCOMFSyncom Formulations (India) | ₹22.83 | +3.21% | +38.8% | ₹2,146 Cr | 28.2 | — |
| INDOCOIndoco Remedies | ₹230.55 | +0.74% | −21.9% | ₹2,128 Cr | — | — |
| PANACEABIOPanacea Biotec | ₹335.85 | −1.22% | −24.2% | ₹2,057 Cr | — | — |
Ask anything about Medi Assist Healthcare Services
Pivot answers on the live chart with evidence you can check, and tests strategies against MEDIASSIST's own history. Try: “Why has MEDIASSIST moved over the last three months?” · “Backtest a 50-day moving-average crossover on MEDIASSIST over five years” · “Compare MEDIASSIST with FREDUN on margins and valuation”
Frequently asked questions about Medi Assist Healthcare Services
What is the share price of Medi Assist Healthcare Services today?
Medi Assist Healthcare Services (NSE: MEDIASSIST) last closed at ₹291.75 on 22 Oct 2026. Its 52-week high is ₹575.55 and its 52-week low is ₹286.05.
What is the market cap of Medi Assist Healthcare Services?
Medi Assist Healthcare Services' market capitalisation is ₹2,179 Cr (₹2,179 Cr) at the 22 Oct 2026 close, ranking 1104th among the NSE companies Pivot tracks.
What is the P/E ratio of Medi Assist Healthcare Services?
Medi Assist Healthcare Services trades at a trailing P/E of 24.1. The median P/E of the 4 closest Pharma & Healthcare peers by market cap is 28.2.
What is the ROE and ROCE of Medi Assist Healthcare Services?
Return on equity was 10.5% in FY26 and return on capital employed was 12.4% in FY26 (consolidated figures).
Is Medi Assist Healthcare Services a debt-free company?
Medi Assist Healthcare Services is close to debt-free: its debt-to-equity ratio was 0 in FY26.
What were Medi Assist Healthcare Services' latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Medi Assist Healthcare Services reported revenue of ₹242 Cr, +28.1% year on year, and net profit of ₹54 Cr, +152.3% year on year.
How has Medi Assist Healthcare Services stock performed over the last year?
Medi Assist Healthcare Services' share price has fallen 46.7% over the past year, −16.4% over three months and −13.9% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of Medi Assist Healthcare Services?
As of 30 Jun 2026: promoters 4.61%, foreign institutions 25.42%, domestic institutions 47.24%, non-institutions 22.74%.
Who are Medi Assist Healthcare Services' competitors?
The listed Pharma & Healthcare companies closest to Medi Assist Healthcare Services by market cap are Fredun Pharmace, Dishman Carbogen Amcis, Vimta Labs, Syncom Formulations (India), Indoco Remedies and Panacea Biotec.
Is Medi Assist Healthcare Services a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Medi Assist Healthcare Services' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on MEDIASSIST against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with M · all NSE stocks · this page as text